Does Rallies show 13F holders for ICLR?

Yes. Rallies tracks hedge fund and 13F ownership data for ICLR, including fund names, share counts, latest tracked quarter, and position changes when available.

Is ICLR research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ICLR. It does not provide personalized investment advice.

ICLR (Icon Plc) Stock Analysis - Hedge Fund Holdings

Icon Plc (ICLR) is a publicly traded Healthcare sector company. As of May 21, 2026, ICLR trades at $115.09 with a market cap of $8.69B and a P/E ratio of 0.00. ICLR moved +1.51% today. Year to date, ICLR is -41.75%; over the trailing twelve months it is -12.86%. Its 52-week range spans $66.57 to $303.69. Analyst consensus is buy with an average price target of $135.57. Rallies surfaces ICLR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns ICLR stock?

Hedge funds tracked by Rallies that own ICLR include Harris Associates, Baupost Group, Glenview Capital, Orbimed Advisors, and Polen Capital. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Icon Plc.

ICLR Key Metrics

Key financial metrics for ICLR
Metric	Value
Price	$115.09
Market Cap	$8.69B
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.00%
52-Week High	$303.69
52-Week Low	$66.57
Volume	0
Avg Volume	0
Revenue (TTM)	$0
Net Income	$0
Gross Margin	0.00%

Top Hedge Funds Holding ICLR

Harris Associates holds 4.35M shares of ICLR, changed +73.35% as of Mar 31, 2026.
Baupost Group holds 405.00K shares of ICLR, changed +0.00% as of Jun 30, 2025.
Glenview Capital holds 371.42K shares of ICLR, changed +0.00% as of Sep 30, 2025.
Orbimed Advisors holds 123.90K shares of ICLR, changed -28.83% as of Sep 30, 2024.
Polen Capital holds 105.21K shares of ICLR, changed -76.28% as of Dec 31, 2025.

Latest ICLR News

ICON stock gains as audit investigation wraps; restatement scope looks contained — May 5, 2026
ICON shares slide as revenue-recognition probe ends, restatement timeline becomes focus — May 1, 2026
ICON jumps as audit probe wraps up; company to restate 2023-2024 results — Apr 29, 2026
ICON (ICLR) slides ahead of April 30 delayed results tied to accounting probe — Apr 28, 2026
ICON (ICLR) slides ahead of April 30 deadline for delayed 2025 results — Apr 26, 2026

ICLR Analyst Consensus

8 analysts cover ICLR: 0 strong buy, 5 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $135.57.

Common questions about ICLR

Who owns ICLR stock?: Hedge funds tracked by Rallies that own ICLR include Harris Associates, Baupost Group, Glenview Capital, Orbimed Advisors, and Polen Capital. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Icon Plc.
Does Rallies show 13F holders for ICLR?: Yes. Rallies tracks hedge fund and 13F ownership data for ICLR, including fund names, share counts, latest tracked quarter, and position changes when available.
Is ICLR research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ICLR. It does not provide personalized investment advice.